Senate Committee on Health passes The Drug Regulatory Authority Bill, 2020

Spread the love

ISLAMABAD:  (Parliament Times)  Senate Standing Committee on National Health Services in its meeting on Thursday passed The Drug Regulatory Authority of Pakistan (Amendment) Bill, 2020 moved by Senator Muhammad Javed Abbasi calling for omission of words non-drug being used for some health and OTC products. The amendment will remove the inconsistency of the definition of the term in the bill and will also help reduce the misuse of the term in case of assurance of safeness, effectiveness, and reasonable pricing of drugs and therapeutic goods.
The Committee was held with Senator Khushbakht Shujaat in the chair here at the
Parliament House on Thursday and was attended among others by Senators Asad Ashraf,
Ghous Niazi, Javed Abbai, Sana Jamali, Shafiq Tareen, Additional Secretary Ministry of
Health and officials from the ministry and DRAP.
The Committee was given a detailed briefing on the present status of COVID-19 in Pakistan
and future plans to combat the pandemic. It was told that the total tests conducted since
February are 2,043,870, total deaths due to COVID-19 are 6,014, 254,286 (90.4%) recoveries
and 20,836 active cases. In the last 24 hours 11,915 tests were conducted, 675 positive
cases were reported and 15 deaths occurred. The country has 493 COVID-19 related
hospitals with 27,540 beds for COVID-19 patients and 1,783 ventilators dedicated for
COVID-19.
Labs and testing facilities The Committee was also told that the possibilities for virtual
hospitals in Pakistan are being explored which will use healthcare workers to provide
assistance and services to patients especially who cannot travel to hospitals. Details
regarding the future plan slowing down the spread of disease, ramping up the healthcare
facilities, making required legislation i.e. national health emergency response act, media
campaign and awareness, capacity building of healthcare workers and financial resources
were also shared.
On questions regarding uneven distribution of labs, testing facilities and protective gears,
the Committee was told that these are decided, established or provided according to
identification of provincial governments and every stakeholder is represented on the forum
of NCOC.

Similar Posts